Table 1 Subtyping of Breast Cancer Based on Immunohistochemistry Classification of Estrogen and Progesterone Receptors and Expression of HER2 Biomarker
From: Breast Cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes
Subtype | n (%) |
|---|---|
Luminal A-like | 910 (28.8) |
Luminal B-like | 1,147 (36.4) |
HER2 Enriched | 633 (20.1) |
Triple-Negative | 463 (14.7) |
Total | 3,153 |